References

1. Balanescu DV, et al. Emerging Concerns in Cardio-Oncology: Immune Checkpoint Inhibitor Cardiotoxicity. 2019. Available at: https://www.acc.org/latest-in-cardiology/articles/2019/06/21/08/45/emerging-concerns-in-cardio-oncology. Accessed August 11, 2021.
2. Blackmon JT, et al. J Neurology. 2016;doi: 10.29245/2572.942X/2016/4.1040.
3. Brahmer JR, et al. J Clin Oncol. 2018;doi:10.1200/JCO.2017.77.6385.
4. Cappelli L, et al. UpToDate. Rheumatologic complications of checkpoint inhibitor immunotherapy. 2020. Available at: https://www.uptodate.com/contents/rheumatologic-complications-of-checkpoint-inhibitor-immunotherapy. Accessed August 11, 2021.
5. Chan KK. Clinical Review. 2020;doi:10.1136/bmj.m736.
6. Chang LS, et al. Endocr Rev. 2019;doi:10.1210/er.2018-00006.
7. Cuzzubbo S, et al. Eur J Cancer. 2017;doi:10.1016/j.ejca.2016.12.001.
8. Del Rivero J, et al. Oncologist. 2020;doi:10.1634/theoncologist.2018-0470.
9. Delaunay M, et al. Eur Respir Rev. 2019;doi:10.1183/16000617.0012-2019.
10. Fan S, et al. Asia Pac J Clin Oncol. 2020;doi:10.1111/ajco.13375.
11. Gupta S, et al. Kidney360. 2020;doi:10.34067/KID.0000852019.
12. Jamal S, et al. J Rheumatol. 2020;doi:10.3899/jrheum.190084.
13. Kitchlu A, et al. Kidney Int Rep. 2020;doi:10.1016/j.ekir.2020.10.002.
14. Michel L, et al. Int J Cardiol Heart Vasc. 2019;doi:10.1016/j.ijcha.2019.100420.
15. Liu YH, et al. Biomed Pharmacother. 2019;doi:10.1016/j.biopha.2019.109437.
16. Liu Y, Wu W. Asia Pac J Clin Oncol. 2020;doi: 10.1111/ajco.13326.
17. Puzanov I, et al. J Immunother Cancer. 2017;doi: 10.1186/s40425-017-0300-z.
18. Ramos-Casals M, et al. Nat Rev Dis Primers. 2020;doi:10.1038/s41572-020-0160-6.
19. Rajha E, et al. Gastroenterol Rep (Oxf). 2020;doi:10.1093/gastro/goz065.
20. Rashdan S, et al. Lancet Respi Med. 2018;doi:10.1016/S2213-2600(18)30172-3.
21. Seidel JA, et al. Trends in Immunotherapy. 2017;doi:10.24294/ti.v1.i1.20.
22. Spain L, et al. ESMO Open. 2019;doi:10.1136/esmoopen-2019-000540.
23. Weber JS, et al. J Clin Oncol. 2015;doi:10.1200/JCO.2014.60.0379.
24. Weinmann SC, et al. Rheumatology (Oxford). 2019;doi:10.1093/rheumatology/kez308.
25. Zhou YW, et al. Front Pharmacol. 2019;doi:10.3389/fphar.2019.01350.

Thank you for participating in this module. Click below to download the certificate.